Welcome
Clearer Decisions. More Personalised Cancer Care.
Evidence-based medical oncology, precision oncology and structured second opinions for patients and families navigating complex cancer decisions.
I am Dr Raman Narang, a medical and hemato-oncologist with a clinical focus on precision oncology, cancer genetics and personalised cancer treatment in the elderly patients as well as the young ones.
Cancer care often involves difficult decisions; whether chemotherapy is necessary, whether molecular testing may change treatment, whether a proposed treatment is appropriate, or whether another option should be considered. My role is to help patients and families understand these decisions clearly and develop a treatment strategy based on the cancer type, stage, biology, overall health and individual priorities.
My areas of interest include solid tumours, hematological malignancies, immunotherapy, targeted therapy, molecular diagnostics and complex second opinions.
Specializing in biomarker-driven cancer treatment using molecular profiling, targeted therapy, and immunotherapy to deliver personalized and evidence-based care.
What do you need help with?
Newly diagnosed with cancer?
Understand the diagnosis, stage and next steps.
Considering a second opinion?
Get a structured review of reports and treatment options.
Have an NGS or molecular report?
Understand whether the findings are clinically relevant.
Featured In: Financial Express • Hindustan Times • Indian Express • Republic World • Times Now • BBC
Clinical Focus
Precision Oncology & Molecular Profiling
Treatment selection based on tumor biology and genomic markers.
Cancer Genetics & Hereditary Risk
Evaluation of inherited cancer risk and family-based screening strategies.
Immunotherapy & Targeted Therapy
Use of biomarker-guided therapies aligned with international standards.
Structured Second Opinion
Independent review of diagnosis, staging, and treatment strategy.
Frequently Asked Questions
Can I get a cancer second opinion online?
Yes. Online cancer second opinions are available for patients who would like an independent review of their diagnosis, investigations, molecular reports or proposed treatment plan. The consultation can usually be completed by video after the relevant medical records have been reviewed.
What reports should I send before consultation?
Please share the most relevant available records, such as the biopsy or pathology report, PET-CT/CT/MRI reports, recent blood tests, discharge summaries, details of previous cancer treatment and any molecular, biomarker or NGS reports. If needed, additional records can be requested after the initial review.
Can I seek a second opinion before starting chemotherapy?
Yes. Before starting chemotherapy or another systemic treatment is often a useful time to seek a second opinion, particularly when there is uncertainty about the treatment choice, duration, sequencing or need for additional testing. A second opinion does not necessarily mean changing the recommended treatment; it can also help confirm that the proposed plan is appropriate.
Can an NGS report change cancer treatment?
Sometimes. NGS and other molecular tests can identify alterations that may influence targeted therapy, immunotherapy, inherited cancer risk assessment or eligibility for clinical trials. However, not every mutation found on an NGS report is clinically actionable. The result needs to be interpreted alongside the cancer type, stage, previous treatment and other clinical factors.
Do you treat patients or only provide second opinions?
Both. Dr Raman Narang provides structured cancer second opinions as well as ongoing medical and hemato-oncology care. Depending on the clinical situation, this may include treatment planning, chemotherapy, targeted therapy, immunotherapy, hormonal therapy and follow-up during or after treatment.
Where can I consult Dr Raman Narang in Delhi?
In-person consultations are available at Dr Raman Narang’s current clinical locations in Delhi. As consultation locations and timings may vary, patients are advised to check the latest appointment details before visiting.
Can patients outside Delhi consult online?
Yes. Patients outside Delhi can request an online consultation for cancer second opinions, treatment-plan review, molecular or NGS report interpretation and selected follow-up consultations. If an in-person examination, procedure or treatment is required, this can be discussed during the consultation.
When the treatment decision is not clear
A cancer second opinion can be useful before starting treatment, when different treatment options have been suggested, after recurrence or progression, or when molecular testing introduces new choices.
The review can include pathology, imaging, previous treatment, molecular or NGS reports and the proposed treatment strategy.
The aim is not simply to offer another opinion, but to help clarify the key treatment decision.
Precision Oncology Approach
Modern cancer treatment is no longer uniform. Precision oncology focuses on understanding the unique biology of each patient’s cancer to guide individualized treatment decisions.
- Molecular profiling → Identifying actionable mutations such as EGFR, ALK, HER2, and others
- Cancer genetics → Evaluating inherited risk through germline testing when appropriate
- Biomarker-driven therapy → Selecting targeted therapy or immunotherapy based on tumor characteristics
- Structured treatment planning → Integrating pathology, imaging, and molecular data
- Multidisciplinary coordination → Aligning systemic therapy with surgery and radiation
This approach allows treatment to be tailored—not only to the disease, but also to the individual—improving outcomes while minimizing unnecessary toxicity.
How Treatment Decisions Are Made in Modern Oncology
Cancer treatment decisions are based on a structured clinical framework that integrates disease stage, tumor biology, patient factors, and available evidence. This ensures that each treatment plan is individualized and clinically justified.
- If the cancer is early-stage and localized
→ Surgery with or without adjuvant therapy is typically considered - If actionable molecular markers are present
→ Targeted therapy may be preferred over conventional chemotherapy - If immunotherapy biomarkers (PD-L1, MSI, TMB) are significant
→ Immunotherapy becomes an important component of treatment - If the patient is elderly or medically frail
→ Treatment intensity is adjusted to balance efficacy and safety - If multiple treatment strategies are available
→ A structured second opinion helps optimize sequencing and outcomes
This decision-making process reflects the shift from standardized protocols to personalized cancer care based on precision oncology principles.
Life after cancer treatment
Finishing treatment does not always mean that the questions are over.
Cancer survivors may need a structured plan for surveillance, late effects of treatment, bone and cardiovascular health, fertility, lifestyle, inherited cancer risk and long-term wellbeing.
A survivorship consultation can help organise these issues into a practical follow-up plan.